https://catalyst-hm.com
America/New_York
America/New_York
America/New_York
20231105T020000
-0400
-0500
EST
20240310T020000
-0500
-0400
EDT
ai1ec-205591@catalyst-hm.com
20240329T014550Z
Grand Rounds,New York
Tuesday, September 7, 2021
12:00-1:00pm
Location
Brooklyn, NY
Speaker
David Rizzieri, MD
20210907T120000
20210907T130000
Brooklyn, NY
0
AML Grand Rounds
free
ai1ec-205593@catalyst-hm.com
20240329T014550Z
Grand Rounds,Texas
Tuesday, September 7, 2021
2:00-3:00pm
Location
Houston, TX
Speaker
David Rizzieri, MD
20210907T140000
20210907T150000
Houston, TX
0
AML Grand Rounds
free
ai1ec-205594@catalyst-hm.com
20240329T014550Z
Grand Rounds,Illinois
Thursday, September 9, 2021
12:00-1:00pm
Location
Chicago, IL
Speaker
Alice S. Mims, MD, MSCR
20210909T120000
20210909T130000
Chicago, IL
0
AML Grand Rounds
free
ai1ec-205595@catalyst-hm.com
20240329T014550Z
Grand Rounds,Maryland
Thursday, September 9, 2021
4:30-5:30pm
Location
Baltimore, MD
Speaker
Alice S. Mims, MD, MSCR
20210909T163000
20210909T173000
Baltimore, MD
0
AML Grand Rounds
free
ai1ec-205596@catalyst-hm.com
20240329T014550Z
Grand Rounds,Ohio
Friday, September 10, 2021
12:00-1:00pm
Location
Canton, OH
Speaker
David Rizzieri, MD
20210910T120000
20210910T130000
Canton, OH
0
AML Grand Rounds
free
ai1ec-205597@catalyst-hm.com
20240329T014550Z
Grand Rounds,New York
Tuesday, September 14, 2021
12:00-1:00pm
Location
Hudson, NY
Speaker
David Rizzieri, MD
20210914T120000
20210914T130000
Hudson, NY
0
AML Grand Rounds
free
ai1ec-205598@catalyst-hm.com
20240329T014550Z
Grand Rounds,New York
Thursday, September 23, 2021
10:00-11:00am
Location
Staten Island, NY
Speaker
Jeffrey E. Lancet, MD
20210923T100000
20210923T110000
Staten Island, NY
0
AML Grand Rounds
free
ai1ec-205599@catalyst-hm.com
20240329T014550Z
Grand Rounds,Texas
Thursday, September 23, 2021
12:00-1:00pm
Location
Temple, TX
Speaker
Alice S. Mims, MD, MSCR
20210923T120000
20210923T130000
Temple, TX
0
AML Grand Rounds
free
ai1ec-205600@catalyst-hm.com
20240329T014550Z
Georgia,Grand Rounds
Friday, September 24, 2021
12:15-1:15pm
Location
Decatur, GA
Speaker
Joshua Zeidner, MD
20210924T121500
20210924T131500
Decatur, GA
0
AML Grand Rounds
free
ai1ec-205602@catalyst-hm.com
20240329T014550Z
Grand Rounds,New York
Monday, September 27, 2021
12:00-1:00pm
Location
Brooklyn, NY
Speaker
David Rizzieri, MD
20210927T120000
20210927T130000
Brooklyn, NY
0
AML Grand Rounds
free
ai1ec-205601@catalyst-hm.com
20240329T014550Z
Grand Rounds,New York
Monday, September 27, 2021
7:30-8:30am
Location
White Plains, NY
Speaker
Hetty Carraway, MD, MBA
20210927T193000
20210927T203000
White Plains, NY
0
AML Grand Rounds
free
ai1ec-205603@catalyst-hm.com
20240329T014550Z
Grand Rounds,Texas
Saturday, October 2, 2021
12:00-1:00pm
Location
Lubbock, TX
Speaker
Tapan M. Kadia, MD
20211002T120000
20211002T130000
Lubbock, TX
0
AML Grand Rounds
free
ai1ec-205605@catalyst-hm.com
20240329T014550Z
Grand Rounds,Illinois
Thursday, October 7, 2021
12:00-1:00pm
Location
Chicago, IL
Speaker
Hetty Carraway, MD, MBA
20211007T120000
20211007T130000
Chicago, IL
0
AML Grand Rounds
free
ai1ec-205604@catalyst-hm.com
20240329T014550Z
Grand Rounds
Thursday, October 14, 2021
12:00-1:00pm
Location
N/A
Speaker
Alice S. Mims, MD, MSCR
20211014T120000
20211014T130000
0
AML Grand Rounds
free
ai1ec-205606@catalyst-hm.com
20240329T014550Z
California,Grand Rounds
Wednesday, October 20, 2021
12:15-1:15pm
Location
Oxnard, CA
Speaker
David Rizzieri, MD
20211020T121500
20211020T131500
Oxnard, CA
0
AML Grand Rounds
free
ai1ec-205607@catalyst-hm.com
20240329T014550Z
Grand Rounds,Pennsylvania
Thursday, October 21, 2021
7:30-8:30am
Location
Philadelphia, PA
Speaker
Tapan M. Kadia, MD
20211021T073000
20211021T083000
Philadelphia, PA
0
AML Grand Rounds
free
ai1ec-205608@catalyst-hm.com
20240329T014550Z
Grand Rounds,New York
Friday, October 22, 2021
8:00-9:00am
Location
Brooklyn, NY
Speaker
Anjali Advani, MD
20211022T080000
20211022T090000
Brooklyn, NY
0
AML Grand Rounds
free
ai1ec-205673@catalyst-hm.com
20240329T014550Z
Grand Rounds
Wednesday, October 27, 2021
12:00-1:00pm
Location
Hoboken, NJ
Speaker
Joshua Zeidner, MD
20211027T120000
20211027T130000
Hoboken, NJ
0
AML Grand Rounds
free
ai1ec-205609@catalyst-hm.com
20240329T014550Z
Grand Rounds
Thursday, October 28, 2021
12:00-1:00pm
Location
N/A
Speaker
Alice S. Mims, MD, MSCR
20211028T120000
20211028T130000
0
AML Grand Rounds
free
ai1ec-205610@catalyst-hm.com
20240329T014550Z
Grand Rounds,Indiana
Wednesday, November 3, 2021
7:30-8:30am
Location
Richmond, IN
Speaker
Joshua Zeidner, MD
20211103T073000
20211103T083000
Richmond, IN
0
AML Grand Rounds
free
ai1ec-205611@catalyst-hm.com
20240329T014550Z
Grand Rounds,Maryland
Friday, November 5, 2021
8:00-9:00am
Location
Salisbury, MD
Speaker
Joshua Zeidner, MD
20211105T080000
20211105T090000
Salisbury, MD
0
AML Grand Rounds
free
ai1ec-205612@catalyst-hm.com
20240329T014550Z
Grand Rounds
Tuesday, November 9, 2021
12:00-1:00pm
Location
Brooklyn, NY
Speaker
Tapan M. Kadia, MD
20211109T120000
20211109T130000
Brooklyn, NY
0
AML Grand Rounds
free
ai1ec-205675@catalyst-hm.com
20240329T014550Z
Grand Rounds
Thursday, November 11, 2021
9:00-10:00am
Location
Fort Lauderdale, FL
Speaker
David Rizzieri, MD
20211111T090000
20211111T100000
Fort Lauderdale, FL
0
AML Grand Rounds
free
ai1ec-205613@catalyst-hm.com
20240329T014550Z
Grand Rounds
Thursday, November 11, 2021
12:00-1:00pm
Location
N/A
Speaker
Tapan M. Kadia, MD
20211111T120000
20211111T130000
0
AML Grand Rounds
free
ai1ec-205676@catalyst-hm.com
20240329T014550Z
Grand Rounds
Thursday, November 11, 2021
1:00-2:00pm
Location
Orlando, FL
Speaker
David Rizzieri, MD
20211111T130000
20211111T140000
Orlando, FL
0
AML Grand Rounds
free
ai1ec-205614@catalyst-hm.com
20240329T014550Z
Grand Rounds,New York
Wednesday, November 17, 2021
1:15-2:15pm
Location
Brooklyn, NY
Speaker
Jeffrey E. Lancet, MD
20211117T131500
20211117T141500
Brooklyn, NY
0
AML Grand Rounds
free
ai1ec-205615@catalyst-hm.com
20240329T014550Z
Arizona,Grand Rounds
Friday, November 19, 2021
12:00-1:00pm
Location
Goodyear, AZ
Speaker
David Rizzieri, MD
20211119T120000
20211119T130000
Goodyear, AZ
0
AML Grand Rounds
free
ai1ec-205616@catalyst-hm.com
20240329T014550Z
Grand Rounds
Monday, November 22, 2021
12:00-1:00pm
Location
Buffalo, NY
Speaker
Anjali Advani, MD
20211122T120000
20211122T130000
Buffalo, NY
0
AML Grand Rounds
free
ai1ec-205617@catalyst-hm.com
20240329T014550Z
Grand Rounds,Indiana
Tuesday, November 30, 2021
8:00-9:00am
Location
Goshen, IN
Speaker
Joshua Zeidner, MD
20211130T080000
20211130T090000
Goshen, IN
0
AML Grand Rounds
free
ai1ec-205618@catalyst-hm.com
20240329T014550Z
Grand Rounds,Tennessee
Wednesday, December 1, 2021
2:00-3:00pm
Location
Nashville, TN
Speaker
Alice S. Mims, MD, MSCR
20211201T140000
20211201T150000
Nashville, TN
0
AML Grand Rounds
free
ai1ec-205896@catalyst-hm.com
20240329T014550Z
Grand Rounds
Updates in Acute Myeloid Leukemia: What are Best Practices for Personalizing Therapy for Patients Within the Department of Veterans Affairs?
REGISTER FOR LIVE VIRTUAL PROGRAM
Friday, July 14, 2023
12:00PM – 1:00PM ET
Please note this virtual program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.
FACULTY
Courtney D. DiNardo, MD, MSCE
Associate Professor, Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
PROGRAM OVERVIEW
In this program, we will discuss how healthcare providers within the Department of Veterans Affairs can improve their treatment of patients with Acute Myeloid Leukemia (AML) by providing updates on key biological features and biomarkers of AML to inform patient assessment with novel therapies. In addition, we will review the latest data in the management of AML and challenges in effectively communicating rationale for therapeutic decisions with patients and caregivers.
TARGET AUDIENCE
This educational activity is intended for US-based hematologists, medical oncologists, and other healthcare providers involved in the management of patients with AML within the Department of Veterans Affairs.
EDUCATIONAL OBJECTIVES
Upon the completion of this program, attendees should be able to:
Analyze current data concerning molecular and genetic markers to inform therapeutic decision-making in AML for patients within the Department of Veterans Affairs
Understand the latest strategies for management of newly diagnosed and relapsed/refractory AML as informed by patient-specific features for patients within the Department of Veterans Affairs
Evaluate current data concerning management of adverse events and implementation of shared decision-making to implement therapy in AML for patients within the Department of Veterans Affairs
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES (ANCC) CREDIT DESIGNATION
Amedco LLC designates this virtually live activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at info@medlearninggroup.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group at info@medlearninggroup.com
REGISTER FOR LIVE VIRTUAL PROGRAM
20230714T120000
20230714T130000
0
Updates in Acute Myeloid Leukemia: What are Best Practices for Personalizing Therapy for Patients Within the Department of Veterans Affairs?
free
thumbnail;https://catalyst-hm.com/wp-content/uploads/2023/07/HM_42L_banner-150x150.jpg;150;150;1,medium;https://catalyst-hm.com/wp-content/uploads/2023/07/HM_42L_banner-300x46.jpg;300;46;1,large;https://catalyst-hm.com/wp-content/uploads/2023/07/HM_42L_banner-1024x157.jpg;1024;157;1,full;https://catalyst-hm.com/wp-content/uploads/2023/07/HM_42L_banner.jpg;1220;187;
ai1ec-205892@catalyst-hm.com
20240329T014550Z
Grand Rounds
Approaches to Improving Care in Chronic Lymphocytic Leukemia Patients Within the Department of Veterans Affairs: Insights from the Experts
REGISTER FOR LIVE VIRTUAL PROGRAM
Thursday, August 10, 2023
12:00PM – 1:00PM ET
Please note this virtual program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific
FACULTY
Lori Leslie, MD
Associate Professor of Medicine
Hackensack Meridian Health School of Medicine
Director of CLL and Indolent Lymphoma
John Theurer Cancer Center
Hackensack, NJ
PROGRAM OVERVIEW
In this activity we will discuss the relevance of specific genetic and molecular markers in Chronic Lymphocytic Leukemia (CLL), review the current evidence concerning the application of minimal residual disease (MRD) monitoring, and emerging strategies and combinations for CLL management in first-line and relapsed/refractory settings. Finally, we will examine the potential adverse events associated with CLL therapeutics, including specific considerations with combination therapies.
TARGET AUDIENCE
This educational activity is intended for community hematologists, oncologists, and clinicians involved in the assessment, monitoring, and treatment of CLL for patients within the Department of Veteran Affairs.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
Evaluate the relevance of specific genetic and molecular markers in CLL for patients within the Department of Veterans Affairs
Summarize current evidence concerning the application of MRD monitoring in CLL for patients within the Department of Veterans Affairs
Assess current and emerging strategies and combinations for CLL management in first-line and relapsed/refractory settings for patients within the Department of Veterans Affairs
Explain potential adverse events associated with CLL therapeutics and considerations with specific combinations for patients within the Department of Veterans Affairs
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES (ANCC) CREDIT DESIGNATION
Amedco LLC designates this virtually live activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at info@medlearninggroup.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group at info@medlearninggroup.com
REGISTER FOR LIVE VIRTUAL PROGRAM
20230810T120000
20230810T130000
0
Approaches to Improving Care in Chronic Lymphocytic Leukemia Patients Within the Department of Veterans Affairs: Insights from the Experts
free
thumbnail;https://catalyst-hm.com/wp-content/uploads/2023/07/HM_43L_banner_footer-150x150.jpg;150;150;1,medium;https://catalyst-hm.com/wp-content/uploads/2023/07/HM_43L_banner_footer-300x46.jpg;300;46;1,large;https://catalyst-hm.com/wp-content/uploads/2023/07/HM_43L_banner_footer-1024x157.jpg;1024;157;1,full;https://catalyst-hm.com/wp-content/uploads/2023/07/HM_43L_banner_footer.jpg;1220;187;